Loading...
XSHE
300753
Market cap345mUSD
Jul 10, Last price  
19.48CNY
1D
4.73%
1Q
-30.43%
IPO
24.95%
Name

Jiangsu Apon Medical Technology Co Ltd

Chart & Performance

D1W1MN
XSHE:300753 chart
P/E
P/S
7.23
EPS
Div Yield, %
0.35%
Shrs. gr., 5y
Rev. gr., 5y
-5.94%
Revenues
340m
-15.89%
120,351,148153,515,561198,301,574246,922,316298,033,812379,647,097443,076,112461,210,894461,210,893323,808,133323,808,133422,170,460403,802,245339,648,012
Net income
-24m
L
31,383,81928,898,91247,703,32157,921,51970,089,803102,343,47196,958,58654,063,72854,063,7330-75,981,3508,277,35810,800,737-24,020,678
CFO
2m
-85.12%
33,493,00038,077,00060,969,00067,076,00078,127,00077,591,00083,339,49918,286,000-24,594,000-23,336,00015,679,0002,332,924
Dividend
May 29, 20250.065 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Jiangsu Apon Medical Technology Co., Ltd. operates within China, specializing in the development, manufacturing, and distribution of various medical devices. Its main offerings include microcomputer and disposable injection pumps, wireless analgesia management systems, and pulse oximeters. The company also supplies specific medical products like sensors tailored for pain management and sprayers designed for nasal care. Established in 2001, the firm's headquarters are situated in Nantong, China.
IPO date
Dec 13, 2018
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122023‑002022‑122022‑002021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT